These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8105060)

  • 1. Buprenorphine-cocaine interactions in mice: effect on locomotor activity and hole-dipping behaviour.
    Jackson HC; Griffin IJ; Nutt DJ
    J Pharm Pharmacol; 1993 Jul; 45(7):636-40. PubMed ID: 8105060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor.
    Smith MA; Gordon KA; Craig CK; Bryant PA; Ferguson ME; French AM; Gray JD; McClean JM; Tetirick JC
    Psychopharmacology (Berl); 2003 May; 167(3):265-73. PubMed ID: 12669175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of long-term chronic buprenorphine treatment on the locomotor and nucleus accumbens dopamine response to acute heroin and cocaine in rats.
    Sorge RE; Stewart J
    Pharmacol Biochem Behav; 2006 Jun; 84(2):300-5. PubMed ID: 16806444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of buprenorphine, butorphanol and nalbuphine on the initiation of intravenous cocaine self-administration in drug naive mice.
    Kuzmin AV; Gerrits MA; Zvartau EE; van Ree JM
    Eur Neuropsychopharmacol; 2000 Dec; 10(6):447-54. PubMed ID: 11115734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse.
    Brown EE; Finlay JM; Wong JT; Damsma G; Fibiger HC
    J Pharmacol Exp Ther; 1991 Jan; 256(1):119-26. PubMed ID: 1988653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats.
    Comer SD; Lac ST; Curtis LK; Carroll ME
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1470-7. PubMed ID: 7903391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement.
    Sorge RE; Rajabi H; Stewart J
    Neuropsychopharmacology; 2005 Sep; 30(9):1681-92. PubMed ID: 15798781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
    Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):146-52. PubMed ID: 14712342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new buprenorphine analogy, thenorphine, inhibits morphine-induced behavioral sensitization in mice.
    Zhao WL; Gong ZH; Liang JH
    Acta Pharmacol Sin; 2004 Nov; 25(11):1413-8. PubMed ID: 15525461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone-buprenorphine interactions: effects on cocaine self-administration.
    Mello NK; Lukas SE; Mendelson JH; Drieze J
    Neuropsychopharmacology; 1993 Nov; 9(3):211-24. PubMed ID: 8280345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned rat.
    Kimmel HL; Tallarida RJ; Holtzman SG
    Psychopharmacology (Berl); 1997 Oct; 133(4):372-7. PubMed ID: 9372537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine and cocaine effects on social behavior of monkeys.
    Crowley TJ; Williams EA; Mikulich SK; Ingersoll NC
    Drug Alcohol Depend; 1993 Feb; 31(3):235-45. PubMed ID: 8462413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidotal effects of buprenorphine on the behavioral alterations accompanying cocaine and combined cocaine-ethanol toxicity.
    Hayase T; Yamamoto Y; Yamamoto K
    Pharmacol Biochem Behav; 2002; 71(1-2):19-27. PubMed ID: 11812504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine's effects on self-administration of smoked cocaine base and orally delivered phencyclidine, ethanol and saccharin in rhesus monkeys.
    Carroll ME; Carmona GN; May SA; Buzalsky S; Larson C
    J Pharmacol Exp Ther; 1992 Apr; 261(1):26-37. PubMed ID: 1560373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of d-amphetamine and buprenorphine combinations on speedball (cocaine+heroin) self-administration by rhesus monkeys.
    Mello NK; Negus SS
    Neuropsychopharmacology; 2007 Sep; 32(9):1985-94. PubMed ID: 17228335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu-opioid receptors are not involved in acute cocaine-induced locomotor activity nor in development of cocaine-induced behavioral sensitization in mice.
    Lesscher HM; Hordijk M; Bondar NP; Alekseyenko OV; Burbach JP; van Ree JM; Gerrits MA
    Neuropsychopharmacology; 2005 Feb; 30(2):278-85. PubMed ID: 15257307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of indatraline and buprenorphine on self-administration of speedball combinations of cocaine and heroin by rhesus monkeys.
    Mello NK; Negus SS
    Neuropsychopharmacology; 2001 Jul; 25(1):104-17. PubMed ID: 11377924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress-related behavioral alterations accompanying cocaine toxicity: the effects of mixed opioid drugs.
    Hayase T; Yamamoto Y; Yamamoto K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2000 Dec; 35(6):402-14. PubMed ID: 11197874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
    Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
    Psychopharmacology (Berl); 2004 Apr; 172(4):422-9. PubMed ID: 14712335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys.
    Winger G; Skjoldager P; Woods JH
    J Pharmacol Exp Ther; 1992 Apr; 261(1):311-7. PubMed ID: 1560376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.